Seres Therapeutics (MCRB) EBITDA Margin (QoQ) (2016 - 2026)
Seres Therapeutics (MCRB) EBITDA Margin (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Seres Therapeutics | 43.82 Mn | 43.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 294,959.00 |
| Mar 31, 2026 | -141,597.00 |
| Dec 31, 2025 | 197,973.00 |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | -1.44 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | -1.33 Mn |
| Dec 31, 2022 | 153,869.00 |
| Sep 30, 2022 | 349,142.00 |
| Jun 30, 2022 | -147,349.00 |
| Mar 31, 2022 | -304,960.00 |
| Dec 31, 2021 | -73,854.00 |
| Sep 30, 2021 | 96,871.00 |
| Jun 30, 2021 | -15,470.00 |
| Mar 31, 2021 | 77,103.00 |
| Dec 31, 2020 | 58,574.00 |
| Sep 30, 2020 | -172,063.00 |
| Jun 30, 2020 | -3,564.00 |
| Mar 31, 2020 | 303.00 |
| Dec 31, 2019 | -853.00 |